PUBLIC COMPANY
saveChugai Pharmaceutical Co Ltd
updated 2mo ago
community read0 votes
🐶 often sniffed alongside
top 4pipeline
2
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 11Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
- phase1Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- phase1Study of AUBE00 in Patients With Solid Tumors
- phase2Study of DONQ52 in Active Celiac Disease
- phase1AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
- phase1Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- phase1A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors
- phase1A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that